History of corticotherapy;Histoire de la corticothérapie

Revue de Medecine Interne

Volumn 34, Issue 5, 2013, Pages 258-263

  Chast, F ^a,b  

^a Hôpitaux Universitaires Paris   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Corticosteroids; Cortisone; Inflammatory diseases; Medicinal chemistry; Pharmacological discovery

Indexed keywords

CORTICOSTEROID; CORTISONE;

ADDISON DISEASE; ALLERGIC DISEASE; CORTICOSTEROID THERAPY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; EYE DISEASE; FLUORIDATION; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HISTORY OF MEDICINE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; METABOLIC DISORDER; RESPIRATORY TRACT DISEASE; RHEUMATIC DISEASE; SHORT SURVEY; SKIN DISEASE;

ADDISON DISEASE; ADRENAL CORTEX HORMONES; ARTHRITIS; CORTISONE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 84876741967     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.12.009     Document Type: Short Survey

References (45)

1. Chast F. Histoire contemporaine des médicaments 1995, La Découverte, Paris.
2. Brown-Séquard C.E. Recherches expérimentales sur la physiologie et la pathologie des capsules surrénales. CR Acad Sci (Paris) 1856, 43:422-425. [542-546].
3. Addison T. On the constitutional and local effects of disease of the supra-renal capsules 1855, Highley S., Londres.
4. Medvei V.C. The history of clinical endocrinology. A comprehensive account of endocrinology from earliest times to the present day 1993, The Parthenon Publishing Group, New York.
5. Osler W. On six cases of Addison's disease with the report of a case greatly benefited by the use of the suprarenal cortical extract. Int Med Magazine 1896, 5:3.
6. Rogoff J.M., Stewart G.N. Suprarenal cortical extracts in suprarenal insufficiency (Addison's disease). J Amer Med Ass 1929, 92:1569-1571.
7. Swingle W.W., Pfiffner J.J. The adrenal cortical hormone. Medicine 1932, 11:371-433.
8. Goris A., Liot A., Goris A. Pharmacie galénique 1942, Masson, Paris.
9. Reichstein T., Von Euw J. über Bestandteile der Nebennieren-Rinde, VI. Trennungsmethoden sowie Isolierung der Substanzen Fa, H und J. Helv Chim Acta 1936, 19:1107-1126.
10. De Fremery P., Laqueur E., Reichstein T., Spanhoff R.W., Uydert I.E. Corticosterone, a crystallized compound with the biological activity of the adrenal-cortical hormone. Nature 1937, 137:26.
11. Selye H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 1942, 30:437-453.
12. Sneader W. Drug discovery, the evolution of modern medicines 2005, J. Wiley & Sons, New York.
13. Grollman A. Physiological and chemical studies on the adrenal cortical hormone. Symp Quant Biol 1937, 5:313.
14. Kendall E.C., Mason H.L., McKenzie B.F., Myers C.S., Koelsche G.A. Isolation in crystalline form of the hormone essential to life from the suprarenal cortex; its chemical nature and physiologic properties. Mayo Clin Proc 1934, 9:245-250.
15. Kendall E.C., Mason H.L., Myers C.S., Allers W.D. A physiologic and chemical investigation of the suprarenal cortex. J Biol Chem 1936, 114:57-58.
16. Sarett L.H. 17-hydroxy-11-dehydrocorticosterone synthesis. J Biol Chem 1946, 162:601-631.
17. Julian P.L., Meyer E.W., Karpel W.J., Ryden Waller I. Sterols. XI. 17 alpha-Hydroxy-11-desoxycorticosterone (Reichstein's Substance " S" ). J Am Chem Soc 1950, 72:5145-5147.
18. Woodward R.B., Sondheimer F., Taub D., Heusler K., McLamore W.M. The total synthesis of steroids. J Am Chem Soc 1952, 74:4223-4251.
19. Hunder G.G., Matteson E.L. Rheumatology practice at Mayo Clinic: the first 40years-1920 to 1960. Mayo Clin Proc 2010, 85:e17-e30.
20. Hench P.S. The potential reversibility of rheumatoid arthritis. Ann Rheum Dis 1949, 8:90-96.
21. Hench P.S., Kendall E.C., Slocumb C.H., Polley H.F. The effects of a hormone of the adrenal cortex - Compound E - and of pitituary adrenocorticotrophic hormone on rheumatoid arthritis. Mayo Clin Proc 1949, 24:277-297.
22. Hench P.S., Kendall E.C., Slocumb C., Barnes A.R., Smith H.L., Polley H.F. The effects of a hormone of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone - Compound E - on the acute phase of rheumatic fever; preliminary report. Mayo Clin Proc 1949, 24:277-297.
23. [7th] International Congress on rheumatic diseases. Ann Rheum Dis 1949;8:302-14 [abstracts].
24. Saenger A.K. Discovery of the wonder drug: from cows to cortisone. Clin Chem 2010, 56:1349-1350.
25. Pickering G.W. Significance of the discovery of the effects of cortisone on rheumatoid arthritis. Lancet 1950, 6620:81-84.
26. Fried J., Sabo E.F. Halogenated corticoids. I. 9a-halogen derivatives of cortisone and hydrocortisone. J Am Chem Soc 1957, 79:1130-1141.
27. Cornell R.C., Stoughton R.B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol 1985, 121:63-67.
28. Coopman S., Degreef H., Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 1989, 121:27-34.
29. Sprague R.G. Cortisone and ACTH, a review of certain physiologic effects and their clinical implications. Am J Med 1951, 10:567-594.
30. Billingham R.E., Krohn P.L., Medawar P.B. Effects of cortisone on survival of skin homografts in rabbits. Br Med J 1951, 1:1157-1163.
31. Küss R., Legrain M., Mathé G., Nedey R., Camey M. Homologous human kidney transplantation, experience with six patients. Postgrad Med J 1962, 38:528-531.
32. Hamburger J., Crosnier J., Dormont J. Experience with 45 renal homotransplantations in man. Lancet 1965, 285:985-992.
33. Küss R., Bourget P. Une histoire illustrée de la greffe d'organes. La grande aventure du siècle 1992, Sandoz éd., Rueil-Malmaison.
34. Solis-Cohen S. The use of adrenal substances in the treatment of asthma. J Am Med Assoc 1900, 34:1164-1169.
35. Boardley J.E., Carey R.A., Harvey A.M. Preliminary observations on the effect of adrenocorticotropic hormone in allergic diseases. Bull Johns Hopkins Hosp 1949, 85:396-410.
36. Randolph T.G., Rollins J.P. The effect of cortisone in bronchial asthma. J Allergy 1950, 21:288-295.
37. Schwartz E. Oral cortisone therapy in intractable bronchial asthma. J Am Med Assoc 1951, 147:1734-1737.
38. Ellul-Micallef R., Borthwick R.C., McHardy G.J. Time course of response to corticosteroids in chronic bronchial asthma. Clin Sci 1972, 43:15P.
39. Brown H.M., Storey G., George W.H. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J 1972, 1:585-590.
40. Costello J.F., Clark T.J.H. Response of patients receiving high dose beclomethasone dipropionate. Thorax 1974, 29:571-573.
41. Barnes P.J. Corticosteroids: the drugs to beat. Eur J Pharmacol 2006, 533:2-14.
42. Henderson J.W. Clinical observations of the use of cortisone in ophthalmic diseases. Proc Staff Meet Mayo Clin 1950, 25:459-462.
43. Gordon D.M. Use of dexamethasone in eye disease. J Am Med Assoc 1960, 172:311-312.
44. Machemer R., Sugita G., Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979, 77:171-180.
45. Chast F. Histoire de la corticothérapie. Corticoïdes et corticothérapie 1996, Ellipses éd., Paris.